{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:31:58Z","timestamp":1761921118032,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002954","name":"Universit\u00e0 degli Studi di Milano - Bicocca","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Guillain-Barr\u00e9 syndrome (GBS) is an inflammatory disease of the peripheral nervous system characterized by rapidly evolving polyneuropathy caused by autoimmune demyelination and\/or axonal degeneration. Since SARS-CoV-2 outbreak, several GBS cases following exposure to coronavirus disease-2019 (COVID-19) have been reported in literature, raising the concern of the latter being a potential trigger event for GBS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 90-year-old Caucasian woman who was admitted to our hospital because of fatigue, worsening gait and leg strength, dysphonia, dysarthria and dysphagia, started 3 weeks after being exposed to COVID-19. Based on clinical presentation GBS was suspected, so she performed a lumbar puncture and electromyography, which confirmed the diagnosis of acute motor and sensory axonal neuropathy (AMSAN) variant. We administered high dose of intravenous immunoglobulin with slight neurological improvement. However, after 2 weeks of hospitalization with maximization of care, her physical condition worsen, manifesting severe frailty. The patient was discharged with home support services for managing parenteral nutrition and intense scheduled physiotherapy. A few days later, the patient experienced a further decline in her clinical condition and died at home.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To the best of our knowledge, we report the oldest woman with GBS AMSAN variant after COVID-19 described in the existing literature. Our case supports further research aimed at improving recognition, characterization and prompt management of neurological diseases related to COVID-19 in older patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-023-03833-1","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T10:03:14Z","timestamp":1677664994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Guillain-Barr\u00e9 syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Chiara","family":"Sidoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Antonella","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-1136","authenticated-orcid":false,"given":"Paolo","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Bellelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"issue":"3","key":"3833_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-0032-1329196","volume":"32","author":"X Arcila-Londono","year":"2012","unstructured":"Arcila-Londono X, Lewis RA. Guillain-Barr\u00e9 syndrome. Semin Neurol. 2012;32(3):179\u201386. https:\/\/doi.org\/10.1055\/s-0032-1329196.","journal-title":"Semin Neurol"},{"issue":"2","key":"3833_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/tmi.13181","volume":"24","author":"VK Wachira","year":"2019","unstructured":"Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007-2017: what has changed? Tropical Med Int Health. 2019;24(2):132\u201342. https:\/\/doi.org\/10.1111\/tmi.13181.","journal-title":"Tropical Med Int Health"},{"issue":"2","key":"3833_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123\u201333. https:\/\/doi.org\/10.1159\/000324710.","journal-title":"Neuroepidemiology"},{"issue":"2","key":"3833_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.nrl.0000117821.35196.0b","volume":"10","author":"KH Levin","year":"2004","unstructured":"Levin KH. Variants and mimics of Guillain Barr\u00e9 syndrome. Neurologist. 2004;10(2):61\u201374. https:\/\/doi.org\/10.1097\/01.nrl.0000117821.35196.0b.","journal-title":"Neurologist"},{"issue":"Pt 9","key":"3833_CR5","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA, Swan AV, Rapha\u00ebl JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review. Brain. 2007;130(Pt 9):2245\u201357. https:\/\/doi.org\/10.1093\/brain\/awm004.","journal-title":"Brain"},{"issue":"1","key":"3833_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/ane.13266","volume":"142","author":"A Whittaker","year":"2020","unstructured":"Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14\u201322. https:\/\/doi.org\/10.1111\/ane.13266.","journal-title":"Acta Neurol Scand"},{"issue":"Pt 1","key":"3833_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33\u201343. https:\/\/doi.org\/10.1093\/brain\/awt285.","journal-title":"Brain"},{"issue":"3","key":"3833_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000073059","volume":"50","author":"M Wittstock","year":"2003","unstructured":"Wittstock M, Benecke R, Zettl UK. Therapy with intravenous immunoglobulins: complications and side-effects. Eur Neurol. 2003;50(3):172\u20135. https:\/\/doi.org\/10.1159\/000073059.","journal-title":"Eur Neurol"},{"issue":"4","key":"3833_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","volume":"6","author":"U Katz","year":"2007","unstructured":"Katz U, Achiron A, Sherer Y, Shoenfeld Y. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev. 2007;6(4):257\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2006.08.011.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3833_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10286-018-0542-y","volume":"29","author":"Z Zaeem","year":"2019","unstructured":"Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update. Clin Auton Res. 2019;29(3):289\u201399. https:\/\/doi.org\/10.1007\/s10286-018-0542-y.","journal-title":"Clin Auton Res"},{"issue":"2","key":"3833_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/jns.12163","volume":"21","author":"S Peric","year":"2016","unstructured":"Peric S, Berisavac I, Stojiljkovic Tamas O, et al. Guillain-Barr\u00e9 syndrome in the elderly. J Peripher Nerv Syst. 2016;21(2):105\u201310. https:\/\/doi.org\/10.1111\/jns.12163.","journal-title":"J Peripher Nerv Syst"},{"issue":"9","key":"3833_CR12","doi-asserted-by":"publisher","first-page":"CD006211","DOI":"10.1002\/14651858.CD006211.pub3","volume":"9","author":"G Ellis","year":"2017","unstructured":"Ellis G, Gardner M, Tsiachristas A, Langhorne P, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2017;9(9):CD006211. https:\/\/doi.org\/10.1002\/14651858.CD006211.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"3833_CR13","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","volume":"267","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179\u201384. https:\/\/doi.org\/10.1007\/s00415-020-09929-7.","journal-title":"J Neurol"},{"issue":"11","key":"3833_CR14","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/ene.14462","volume":"27","author":"P De Sanctis","year":"2020","unstructured":"De Sanctis P, Doneddu PE, Vigan\u00f2 L, Selmi C, Nobile-Orazio E. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. A systematic review. Eur J Neurol. 2020;27(11):2361\u201370. https:\/\/doi.org\/10.1111\/ene.14462.","journal-title":"Eur J Neurol"},{"issue":"2","key":"3833_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jmv.26382","volume":"93","author":"P Campana","year":"2021","unstructured":"Campana P, Flocco V, Aruta F, Cacciatore F, Abete P. Can aldosterone increase interleukin-6 levels in Covid-19 pneumonia? J Med Virol. 2021;93(2):622\u20133. https:\/\/doi.org\/10.1002\/jmv.26382.","journal-title":"J Med Virol"},{"key":"3833_CR16","doi-asserted-by":"publisher","first-page":"117263","DOI":"10.1016\/j.jns.2020.117263","volume":"420","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Kataria S, Tandon M, et al. Guillain Barr\u00e9 syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series. J Neurol Sci. 2021;420:117263. https:\/\/doi.org\/10.1016\/j.jns.2020.117263.","journal-title":"J Neurol Sci"},{"issue":"4","key":"3833_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","volume":"268","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133\u201370. https:\/\/doi.org\/10.1007\/s00415-020-10124-x.","journal-title":"J Neurol"},{"issue":"7","key":"3833_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10072-020-04484-5","volume":"41","author":"A Assini","year":"2020","unstructured":"Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020;41(7):1657\u20138. https:\/\/doi.org\/10.1007\/s10072-020-04484-5.","journal-title":"Neurol Sci"},{"issue":"6","key":"3833_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurol.2020.04.007","volume":"176","author":"H El Otmani","year":"2020","unstructured":"El Otmani H, El Moutawakil B, Rafai MA, et al. Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence! Rev Neurol (Paris). 2020;176(6):518\u20139. https:\/\/doi.org\/10.1016\/j.neurol.2020.04.007.","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"3833_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.34172\/icnj.2020.18","volume":"7","author":"H Mozhdehipanah","year":"2020","unstructured":"Mozhdehipanah H, Paybast S, Gorji R. Guillain\u2013Barr\u00e9 syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature. Int Clin Neurosci J. 2020;7(3):156\u201361.","journal-title":"Int Clin Neurosci J"},{"issue":"7","key":"3833_CR21","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00415-020-09849-6","volume":"267","author":"M Padroni","year":"2020","unstructured":"Padroni M, Mastrangelo V, Asioli GM, et al. Guillain-Barr\u00e9 syndrome following COVID-19: new infection, old complication? J Neurol. 2020;267(7):1877\u20139. https:\/\/doi.org\/10.1007\/s00415-020-09849-6.","journal-title":"J Neurol"},{"key":"3833_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233\u20135. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.062.","journal-title":"J Clin Neurosci"},{"issue":"26","key":"3833_CR23","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574\u20136. https:\/\/doi.org\/10.1056\/NEJMc2009191.","journal-title":"N Engl J Med"},{"issue":"2","key":"3833_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/jmv.26289","volume":"93","author":"P Manganotti","year":"2021","unstructured":"Manganotti P, Bellavita G, D'Acunto L, et al. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barr\u00e9 syndrome and polyneuritis cranialis in COVID-19 patients: a case series. J Med Virol. 2021;93(2):766\u201374. https:\/\/doi.org\/10.1002\/jmv.26289.","journal-title":"J Med Virol"},{"issue":"1","key":"3833_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s41983-021-00310-7","volume":"57","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA. Guillain-Barre syndrome in 220 patients with COVID-19. Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):55. https:\/\/doi.org\/10.1186\/s41983-021-00310-7.","journal-title":"Egypt J Neurol Psychiatr Neurosurg"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-03833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-023-03833-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-03833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T14:04:33Z","timestamp":1699365873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-023-03833-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3833"],"URL":"https:\/\/doi.org\/10.1186\/s12877-023-03833-1","relation":{},"ISSN":["1471-2318"],"issn-type":[{"type":"electronic","value":"1471-2318"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient signed a consent form to receive hospital care and to authorize the use of personal health information for academic purposes. The consent form is archived at San Gerardo Hospital. ASST Monza, together with the medical record. Ethics approval is not required given the nature of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient signed a consent form for publication of clinical information. The consent form is archived at San Gerardo Hospital ASST Monza, together with the medical record.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}